Eight major RCTs of GLP-1RAs have investigated the cardiovascular outcomes, including the ELIXA trial of lixisenatide (250), the EXSCEL trial of exenatide ER (251), the LEARDER trial of liraglutide (252), the SUSTAIN-6 trial of subcutaneous semaglutide (253), the HARMONY trial of albiglutide (228), the REWIND trial of dulaglutide (254), the PIONEER trial of oral semaglutide (255), and the SELECT trial of subcutaneous semaglutide (199)
Gating strategy (right)
Yes, glutathione helps improve skin brightness and radiance over time by supporting melanin regulation and reducing oxidative stress
2.6 Confounding covariates The analyses included a set of potential individual-level and household-level covariates
Reconstituted / liquid & nasal sprays: refrigerate at 28C
Expected weight loss outcomes : While many patients experience significant reductions, the percentage of weight loss can vary widely